Australia markets open in 5 hours 51 minutes

Easywell Biomedicals, Inc. (1799.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
70.10-0.20 (-0.28%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 8.54B
Enterprise value 8.58B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)30.23
Price/book (mrq)13.94
Enterprise value/revenue 31.59
Enterprise value/EBITDA -100.36

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3225.84%
S&P500 52-week change 322.38%
52-week high 372.50
52-week low 319.39
50-day moving average 363.32
200-day moving average 339.16

Share statistics

Avg vol (3-month) 3238.41k
Avg vol (10-day) 3135.9k
Shares outstanding 5121.87M
Implied shares outstanding 6121.87M
Float 8N/A
% held by insiders 156.42%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 426 July 2010
Last split factor 2700:1000
Last split date 330 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -53.31%
Operating margin (ttm)-50.31%

Management effectiveness

Return on assets (ttm)-8.52%
Return on equity (ttm)-24.41%

Income statement

Revenue (ttm)271.63M
Revenue per share (ttm)2.37
Quarterly revenue growth (yoy)45.20%
Gross profit (ttm)N/A
EBITDA -121M
Net income avi to common (ttm)-144.82M
Diluted EPS (ttm)-1.25
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)348.03M
Total cash per share (mrq)3
Total debt (mrq)386.34M
Total debt/equity (mrq)61.93%
Current ratio (mrq)3.98
Book value per share (mrq)5.29

Cash flow statement

Operating cash flow (ttm)-151.45M
Levered free cash flow (ttm)-117.85M